CAS No 61-75-6 , (2-bromophenyl)methyl-ethyl-dimethylazanium Search by region : India

Name: (2-bromophenyl)methyl-ethyl-dimethylazanium
Synonyms: Bretylium tosilate; Bretylium p-toluenesulfonate; Darenthin; Bretylan;4-methylbenzenesulfonate;(2-bromophenyl)methyl-ethyl-dimethylazanium;Bretylol; 61-75-6; Ornid; Bretylate;
CAS Registry Number:61-75-6
Safety Statements: A poison by ingestion, intraperitoneal, subcutaneous, intravenous, and intramuscular routes. An anti-adrenergic agent and antiarrhythmic cardiac depressant. When heated to decomposition it emits very toxic fumes of SOx, NH3, NOx, and Br−. See also SULFONATES.
EINECS: 200-516-8
Molecular Weight: 414.35706
InchiKey: KVWNWTZZBKCOPM-UHFFFAOYSA-M
InChI: InChI=1S/C11H17BrN.C7H8O3S/c1-4-13(2,
3)9-10-7-5-6-8-11(10)12;1-6-2-4-7(5-3-6)11(8,9)10/h5-8H,4,9H2,
1-3H3;2-5H,1H3,(H,8,9,10)/q+1;/p-1
Molecular Formula: C₁₈H₂₄BrNO₃S
Molecular Structure:

Related products

Select to

61-75-6 Bretylium Tosylate

Manus Aktteva null
Tel: +91-(79)-65123395
Fax: +91-(79)-26463395
Address: 303, 3rd Floor, Royale Manor, Law Garden, Dhulia Kot Road, Ellisbridge, Ahmedabad, Gujarat 380006, null,nullIndia

61-75-6 Bretylium Tosylate

Bretylium Tosylate
J.INC. [Manufacturer]
Tel: +91 79 30071152, 30071190, 30071175, 30071153
Fax: +91 79 30071176, 26574630
Address: # 95, Rangwala Towers, Law garden, Ellisbridge, Ahmedabad 380006, Gujarat State, India. 380006 AhmedabadINDIA Ahmedabad,nullIndia

Select to

1/1

References of (2-bromophenyl)methyl-ethyl-dimethylazanium

Title: Bretylium Tosylate
CAS Registry Number: 61-75-6
CAS Name: 2-Bromo-N-ethyl-N,N-dimethylbenzenemethanaminium salt with 4-methylbenzenesulfonic acid (1:1)
Synonyms: (o-bromobenzyl)ethyldimethylammonium p-toluenesulfonate; N-ethyl-N-o-bromobenzyl-N,N-dimethylammonium tosylate
Trademarks: Bretylate (GSK); Bretylol (GSK)
Molecular Formula: C18H24BrNO3S
Molecular Weight: 414.36
Percent Composition: C 52.18%, H 5.84%, Br 19.28%, N 3.38%, O 11.58%, S 7.74%
Literature References: Prepn: Copp, Stephenson, US 3038004 (1962 to Burroughs Wellcome). Metabolism: R. Kuntzman et al., Clin. Pharmacol. Ther. 11, 829 (1970). Toxicity study: E. I. Goldenthal, Toxicol. Appl. Pharmacol. 18, 185 (1971). Review of pharmacology: R. H. Heissenbuttel, J. T. Bigger, Ann. Intern. Med. 91, 229-238 (1979); R. J. Lee et al., in Pharmacological and Biochemical Properties of Drug Substances vol. 2, M. E. Goldberg, Ed. (Am. Pharm. Assoc., Washington, DC, 1979) pp 148-164. Comprehensive description: J. E. Carter et al., Anal. Profiles Drug Subs. 9, 71-86 (1980).
Properties: Crystalline powder, mp 97-99°. Extremely bitter taste. uv max: 278, 271, 264 nm. Freely sol in water, methanol, ethanol. Practically insol in ether, ethyl acetate, hexane. LD50 in mice (mg/kg): 400 orally; 250 i.m. (Goldenthal).
Melting point: mp 97-99°
Absorption maximum: uv max: 278, 271, 264 nm
Toxicity data: LD50 in mice (mg/kg): 400 orally; 250 i.m. (Goldenthal)
Therap-Cat: Antiadrenergic; antiarrhythmic (class III).
Keywords: Antiarrhythmic.